HIV & CANCER Issue | Spring 2013

HIV and cancer may sound like a double dose of despair, but the fact that we’re devoting this issue of Spotlight to the subject is not all bad news. Millions of people with HIV now receive life-saving antiretroviral therapy. As more and more people with HIV live much longer lives, researchers are rushing to understand what the implications are. How does chronic HIV infection affect cancer rates? And how can we extend the lessons learned from HIV/AIDS to strengthen cancer treatment in the developing world? Click here for the latest issue.

 

---

 

From the Ground Up is a three-volume collection of best practices and lessons learned contributed by over 320 distinguished HIV/AIDS professionals from around the globe, with a special focus on sub-Saharan Africa. Learn more and order the publication.

 

Plan to treat 'super-carriers' offers new hope

"One in four people infected with the Aids virus in Southern Africa are hyper-infectious super-carriers, scientists at Harvard University have discovered. By targeting these individuals for treatment, the scientists hope it may be possible to counter the rising number of new HIV infections in the worst-affected parts of the world in what could be a major breakthrough in the fight against the spread of Aids." Read more....

 

More recent news

Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in botswana: results from a clinical trial.

High Prevalence of Hypertension and Placental Insufficiency, but No In Utero HIV Transmission, among Women on HAART with Stillbirths in Botswana.

More recent papers